- Home
- TOMZ vs MIRA Comparison
TOMZ vs MIRA Comparison
Compare TOMZ & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- MIRA
- Stock Information
- Founded
- TOMZ 1979
- MIRA 2020
- Country
- TOMZ United States
- MIRA United States
- Employees
- TOMZ N/A
- MIRA N/A
- Industry
- TOMZ Diversified Commercial Services
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- MIRA Health Care
- Exchange
- TOMZ Nasdaq
- MIRA Nasdaq
- Market Cap
- TOMZ 22.6M
- MIRA 19.5M
- IPO Year
- TOMZ N/A
- MIRA 2023
- Fundamental
- Price
- TOMZ $0.98
- MIRA $1.66
- Analyst Decision
- TOMZ Strong Buy
- MIRA Strong Buy
- Analyst Count
- TOMZ 1
- MIRA 2
- Target Price
- TOMZ $3.50
- MIRA $14.00
- AVG Volume (30 Days)
- TOMZ 25.5K
- MIRA 3.7M
- Earning Date
- TOMZ 08-04-2025
- MIRA 08-12-2025
- Dividend Yield
- TOMZ N/A
- MIRA N/A
- EPS Growth
- TOMZ N/A
- MIRA N/A
- EPS
- TOMZ N/A
- MIRA N/A
- Revenue
- TOMZ $8,201,313.00
- MIRA N/A
- Revenue This Year
- TOMZ $3.66
- MIRA N/A
- Revenue Next Year
- TOMZ $139.63
- MIRA N/A
- P/E Ratio
- TOMZ N/A
- MIRA N/A
- Revenue Growth
- TOMZ 19.09
- MIRA N/A
- 52 Week Low
- TOMZ $0.60
- MIRA $0.73
- 52 Week High
- TOMZ $1.50
- MIRA $2.81
- Technical
- Relative Strength Index (RSI)
- TOMZ 48.29
- MIRA 56.83
- Support Level
- TOMZ $0.91
- MIRA $1.60
- Resistance Level
- TOMZ $1.01
- MIRA $2.09
- Average True Range (ATR)
- TOMZ 0.04
- MIRA 0.19
- MACD
- TOMZ -0.00
- MIRA 0.00
- Stochastic Oscillator
- TOMZ 58.25
- MIRA 55.44
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.